ReNaFoBiS/FRISBI Webinar. Structural biology in industry : the NovAliX perspective By Denis Zeyer (CEO NovAliX ), PhD April 21, 2021 08:00 PM Paris
Register in advance for this webinar: https://zoom.us/webinar/register/WN_Fq-wVPQaQoSieSwnIHuzdQ After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speaker : Denis Zeyer (CEO NovAliX ), PhD Denis earned his M.Sc. in biological crystallography and NMR at the Louis Pasteur University (Strasbourg, France). His Ph.D. in protein X-ray crystallography (with Dr. Jean-Paul Renaud and Dr. Dino Moras at the Institute of Genetics and Molecular and Cellular Biology, Strasbourg, France, in collaboration with Bristol Myers Squibb).In 2003 Denis built structural biology and biophysics groups and launched the research services business of AliX pharmaceuticals. In that capacity he has been instrumental in building a sound client base including major pharmaceutical companies; establishing a reputation for scientific excellence and reliability; and in technical improvements though internal and external innovations. Denis was appointed CEO of AliX in 2008 and has been CEO of NovAliX since its inception. He has been instrumental in the implementation of Novalix’ cryo-electron microscopy platform in 2015 and its subsequent development with a strong focus for the use of cryoEM in SBDG. ------------------------- Jean Cavarelli Professor of Structural Biology "Structural biology of epigenetic targets" Department of Integrated structural biology IGBMC,UMR7104 CNRS-UNISTRA, INSERM U 1258 phone : +33 (0)3 69 48 52 74 ######################################################################## To unsubscribe from the CCP4BB list, click the following link: https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1 This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list hosted by www.jiscmail.ac.uk, terms & conditions are available at https://www.jiscmail.ac.uk/policyandsecurity/
